ISSCA to Host Sponsored Regenerative Medicine Symposium in Caracas, Venezuela Dec. 1, 2018

International Society for Stem Cell Application (ISSCA), in keeping with its mission to promote regenerative medicine in clinical applications and provide clinical stem cell therapy training to physicians neworldwide, announces plans to host the  World Symposium on Regenerative Medicine and Cell Therapies: “Adult Stem Cells. The immediate future of Medicine”  in Caracas, Venezuela December 1, 2018.

Global Stem Cells Group (GSCG) CEO and ISSCA Vice President Benito Novas says the symposium is an important event for both organizations’ commitment to spreading knowledge and physician training in regenerative medicine to medical professionals worldwide. This commitment includes strategies to accommodate countries like Venezuela that lack the resources to train physicians to implement regenerative medicine procedures in clinical settings.

“Global Stem Cells Group understands the difficult financial conditions that are depriving Venezuelans of essential advances in medicine including cellular therapies that are being used to improve the quality of life for patients in countries around the world,” says Novas. “GSCG is committed to providing regenerative medicine training and education to physicians everywhere.”

According to Novas, the dire state of Venezuela ‘s health care system is a call-to-action for ISSCA and Global Stem Cells Group Group is sponsoring the event and funding 50 percent of event fee costs to ensure most Venezuelan physicians can attend.

The goal is make economically and therapeutically viable regenerative medicine therapies available to Venezuelans by training and educating physicians throughout the country in stem cell therapies and protocols they can provide to patients in their clinics.

“The opportunity to sponsor this important symposium is very gratifying to us, as it resonates with GSCG’s core mission to bring regenerative medicine to countries around the world,” Novas says. “We’re driven by our conviction that stem cell medicine will bring transformative changes to the healthcare industry at a global level.  

“Regenerative cellular therapies are already replacing invasive treatment practices and improving quality of life outcomes for patients suffering from illnesses and injuries that are not treatable with traditional medicine, he says. “Global Stem Cells Group is motivated to take this first step toward making economically and therapeutically viable regenerative medicine therapies available to Venezuelans.

“This symposium is an important step toward making regenerative medicine education and training available to physicians in Venezuela.”

Symposium topics of focus include:

• Clinical applications for regenerative medicine to treat sports injuries
• Stem cell procedures to treat erctile dysfunction
• How mesenchymal stem cells contribute to renal repair in the treatment of acute tubular epithelial injury
• Management of aging at the cellular level
• Managing advanced aging with combined treatment plans that include surgical procedures
• Restoration and assited hair transplantation treatments with biomaterials and growth factors

More than 16  experts in the field of regenerative medicine will be featured speakers at the event, including:

• Silvina Pastrana, Medical Director of Stem Cells Center Buenos Aires (Argentina), who will discuss stem cell therapy fundamentals and protocols in the medical office
• Jose Benitez, M.D., Medical Director of Boston Médical Group (Spain), whose lecture will focus on the most recent successful regenerative medicine clinical trial for treating erectile diffusion.

The World Symposium on Regenerative Medicine and Cell Therapies will be held Dec. 1, 2018 at the Marriott Hotel in Caracas, Venezuela. For more information and registration, visit the symposium website, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cells Applications

The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine. Their code of ethics emphasizes principles of morals and ethical conducts.

At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative
medicine and make it available to benefit patients both nationally and globally.

For more information, please visit https://www.issca.us/ or send an email to info@stemcellsgroup.com